News
USMCI Conducting Phase II Clinical Trial for Breast Cancer Vaccine
The United States Military Cancer Institute's (USMCI) Clinical
Trials Group is engaged in ground-breaking research working towards
cancer solutions in both military and civilian populations. One
exciting study in which USMCI is currently involved is a prospective,
randomized, multi-center Phase, II clinical trial investigating whether
a new vaccine can prevent recurrence in disease-free, conventionally
treated, node-positive and high-risk node-negative breast cancer
patients who are at significant risk for recurrence. > More